文献速递细菌感染、耐药与抗菌药物医院感染防控新发突发、热带与寄生虫病

多重耐药革兰阴性菌血流感染的快速微生物检测及其治疗意义

Rapid microbiological tests for bloodstream infections due to multidrug resistant Gram-negative bacteria: therapeutic implications.
PubMed 文献 · Clin Microbiol Infect · 2019-10-11

本文为叙述性综述,讨论从阳性血培养或血流感染患者血液中快速鉴定多重耐药革兰阴性菌(MDR-GNB)及药敏试验(AST)的多种快速检测方法的优势与局限,并汇总其改善治疗决策和抗菌药物管理的证据。新型分子与表型快速检测有望缩短有效治疗时间并减少抗生素滥用,但其对实际治疗决策和患者结局的影响仍复杂,实施时需考虑可行性、人员配置及本地微生物流行病学。

要点

  • 快速鉴定与药敏检测可缩短有效治疗时间并减少抗生素滥用。
  • 实施新型快速检测需评估可行性、人员配置和本地流行病学。
  • 快速识别特定耐药机制对指导靶向治疗可能至关重要。

核心结论

  • 新型分子与表型快速检测有望通过缩短有效治疗时间和减少抗生素滥用,对患者结局和抗菌药物管理产生有利影响,但其对实际治疗决策和患者结局的影响仍复杂。

研究设计与样本

  • 叙述性综述,通过归纳性PubMed检索相关文献,结构包括阳性血培养快速检测、全血直接快速检测及治疗意义三部分。

主要发现

  • 从阳性血培养或血流感染患者血液中快速鉴定MDR-GNB及药敏的多种快速检测已可用,但耐药性在鉴定病原体和/或药敏试验前可能未被识别。

临床怎么用

  • 实施新型快速检测时需仔细考虑可行性、人员可用性及对本地微生物流行病学的详细了解。

局限性

  • 关于快速检测对实际治疗决策和患者结局影响的解读仍复杂,缺乏高级别可比性证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Treating severe infections due to multidrug-resistant Gram-negative bacteria (MDR-GNB) is one of the most important challenges for clinicians worldwide, partly because resistance may remain unrecognized until identification of the causative agent and/or antimicrobial susceptibility testing (AST). Recently, some novel rapid test for identification and/or AST of MDR-GNB from positive blood cultures or the blood of patients with bloodstream infections (BSIs) have become available. OBJECTIVES: The objective of this narrative review is to discuss the advantages and limitations of different rapid tests for identification and/or AST of MDR-GNB from positive blood cultures or the blood of patients with BSI, as well as the available evidence on their possible role to improve therapeutic decisions and antimicrobial stewardship. SOURCES: Inductive PubMed search for publications relevant to the topic. CONTENT: The present review is structured in the following way: (a) rapid tests on positive blood cultures; (b) rapid tests directly on whole blood; (c) therapeutic implications. IMPLICATIONS: Novel molecular and phenotypic rapid tests for identification and AST show the potential for favourably influencing patients' outcomes and results of antimicrobial stewardship interventions by reducing both the time to effective treatment and the misuse of antibiotics, although the interpretation about their impact on actual therapeutic decisions and patients' outcomes is still complex. Factors such as feasibility and personnel availability, as well as the detailed knowledge of the local microbiological epidemiology, need to be considered very carefully when implementing novel rapid tests in laboratory workflows and algorithms. Providing high-level, comparable evidence on the clinical impact of rapid identification and AST is becoming of paramount importance for MDR-GNB infections, since in the near future rapid identification of specific resistance mechanisms could be crucial for guiding rapid, effective, and targeted therapy against specific resistance mechanisms.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Giacobbe DR, Giani T, Bassetti M, et al. Rapid microbiological tests for bloodstream infections due to multidrug resistant Gram-negative bacteria: therapeutic implications. Clin Microbiol Infect. 2019. PMID: 31610299. doi:10.1016/j.cmi.2019.09.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。